Cost-effectiveness analysis of community acquired pneumonia treatment in multidisciplinary hospitalsDownload in PDF
We conducted a cost-effectiveness analysis of community acquired pneumonia (CAP) treatment in multidisciplinary hospitals using the results of epidemiological study.
Material and methods
Markov model was used to evaluate the costs and effectiveness of treatment for CAP in hospitalized patients in common clinical practice and according to current guidelines. The primary endpoint was a rate of recovery. We measured both direct and indirect costs.
Cost of CAP treatment according to guidelines and in real clinical practice was 59876,06 and 68795,06 Rubles, respectively, while cost-effectiveness ratio was 66781,24 and 81607,72 Rub, respectively.
Treatment of CAP according to the national recommendation is justified due to a lower cost and a higher effectiveness.
Community-acquired pneumonia, cost-effectiveness analysis, antibacterial treatment.